Clarus Therapeutics Hldgs Inc (CRXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRXT | PHIO | CMND | ||
| Company | Clarus Therapeutics Hldgs Inc | Phio Pharmaceuticals Corp | Clearmind Medicine Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0650 | 2.38 | 1.3600 | ||
| High | 0.0749 | 2.55 | 1.3600 | ||
| Low | 0.0475 | 2.36 | 1.3000 | ||
| Last | 0.0475 | 2.53 | 1.3400 | ||
| Change | -0.0215 | +0.15 | -0.0200 | ||
| % Change | -31.16% | +6.30% | -1.47% | ||
| Volume | 2,737,100 | 32,569 | 34,747 | ||
| 20-Day Average Volume | 4,348,840 | 53,363 | 117,817 | ||
| Previous Close | 0.0690 | 2.38 | 1.3600 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2088 | 2.80 | 1.4200 | ||
| 20-Day Raw Stochastic | 0.00% | 23.64% | 16.67% | ||
| 20-Day Relative Strength | 26.48% | 44.13% | 47.11% | ||
| Weighted Alpha | -96.72 | -69.01 | -59.99 | ||
| Today's Opinion | 100% Sell | 100% Sell | 8% Buy | ||
| Previous Opinion | 100% Sell | 100% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -69.75% since 08/29/22 | +13.45% since 11/14/24 | -8.84% since 11/14/24 | ||
| Low | 0.0475 on 09/06/22 | 2.17 on 11/15/24 | 1.2900 on 11/20/24 | ||
| High | 0.1400 on 08/30/22 | 2.66 on 11/19/24 | 1.5300 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -84.34% since 08/05/22 | -20.44% since 10/21/24 | -12.99% since 10/21/24 | ||
| Low | 0.0475 on 09/06/22 | 2.17 on 11/15/24 | 1.2900 on 11/20/24 | ||
| High | 0.3489 on 08/15/22 | 3.70 on 11/07/24 | 1.5900 on 10/25/24 | ||
| 3-Month | |||||
| %Chg | -90.08% since 06/06/22 | -17.86% since 08/21/24 | +3.08% since 08/21/24 | ||
| Low | 0.0475 on 09/06/22 | 2.17 on 11/15/24 | 1.1820 on 09/06/24 | ||
| High | 0.4659 on 06/07/22 | 4.00 on 09/18/24 | 1.8100 on 10/18/24 | ||
| 6-Month | |||||
| %Chg | -93.21% since 03/04/22 | -63.01% since 05/21/24 | +11.67% since 05/21/24 | ||
| Low | 0.0475 on 09/06/22 | 2.17 on 11/15/24 | 0.9512 on 06/11/24 | ||
| High | 3.9400 on 04/20/22 | 7.11 on 05/28/24 | 2.3000 on 07/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,471 | 2,511 | 2,303 | ||
| Shares Outstanding, K | 52,021 | 1,055 | 1,693 | ||
| Annual Sales | 13,960,000 | 0 | 0 | ||
| Annual Net Income | -40,620,000 | -10,830,000 | -8,620,000 | ||
| Last Quarter Sales | 4,050,000 | 0 | 0 | ||
| Last Quarter Net Income | -10,690,000 | -1,520,000 | -2,090,000 | ||
| 60-Month Beta | 1.96 | 1.46 | 1.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/18/22 | -1.54 on 11/14/24 | -0.59 on 09/16/24 | ||
| Latest Earnings Date | 08/22/22 | 11/14/24 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||